Clinical Trials Browser

Phase 2 × Gastric Adenocarcinoma × Drug Evaluation × Clear all

NCT04121039 2019-10-09

Study of the Apatinib Combine With POF Versus POF in Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Gastric Adenocarcinoma